STALEY CAPITAL ADVISERS’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Sell |
75,000
-5,000
| -6% | -$38.6K | 0.02% | 133 |
|
|
2025
Q1 | $475K | Buy |
80,000
+30,000
| +60% | +$178K | 0.02% | 142 |
|
|
2024
Q4 | $666K | Buy |
50,000
+10,000
| +25% | +$133K | 0.03% | 124 |
|
|
2024
Q3 | $325K | Hold |
40,000
| – | – | 0.01% | 155 |
|
|
2024
Q2 | $340K | Hold |
40,000
| – | – | 0.02% | 151 |
|
|
2024
Q1 | $694K | Hold |
40,000
| – | – | 0.03% | 121 |
|
|
2023
Q4 | $513K | Hold |
40,000
| – | – | 0.03% | 132 |
|
|
2023
Q3 | $1.48M | Buy |
40,000
+10,000
| +33% | +$370K | 0.08% | 84 |
|
|
2023
Q2 | $1.21M | Buy |
30,000
+12,000
| +67% | +$483K | 0.07% | 94 |
|
|
2023
Q1 | $1.31M | Hold |
18,000
| – | – | 0.07% | 92 |
|
|
2022
Q4 | $1.48M | Hold |
18,000
| – | – | 0.09% | 84 |
|
|
2022
Q3 | $1.7M | Buy |
18,000
+1,000
| +6% | +$94.5K | 0.11% | 74 |
|
|
2022
Q2 | $3.31M | Buy |
17,000
+5,000
| +42% | +$974K | 0.2% | 59 |
|
|
2022
Q1 | $2.79M | Buy |
12,000
+2,000
| +20% | +$465K | 0.14% | 73 |
|
|
2021
Q4 | $3.94M | Hold |
10,000
| – | – | 0.19% | 65 |
|
|
2021
Q3 | $4.48M | Hold |
10,000
| – | – | 0.24% | 62 |
|
|
2021
Q2 | $3.89M | Hold |
10,000
| – | – | 0.2% | 61 |
|
|
2021
Q1 | $3.59M | Buy |
+10,000
| New | +$3.59M | 0.2% | 62 |
|